Evidence map›Paper›PMID 31989234›Full record

ReviewDer Pathologe2020

[Cytology of primary lung cancer].

Marianne Engels

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Pathologe, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Marianne EngelsInstitut für Pathologie, Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland. marianne.engels@uk-koeln.de.
University Hospital Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn addition to histological examinations, cytological samples are also being evaluated with increasing frequency for the diagnosis of lung carcinoma.

objectivesPossible applications of and techniques for cytological examinations are presented. Typical morphologies of primary lung cancer and metastatic disease are shown. MATERIAL AND

methodsSamples were obtained during bronchoscopy, serous effusion fluid, and fine-needle aspiration cytology. Special technical features of the cytological samples are discussed. Cytomorphology of pulmonary adenocarcinoma, squamous-cell carcinoma, and small-cell lung carcinoma are shown.

resultsThere are clear-cut diagnostic criteria for the main subtypes of primary lung carcinoma.

conclusionsCytological examination is a valuable addition to histology for lung carcinoma diagnostics.

Indexed as

Biopsy, Fine-NeedleBronchoscopyCytodiagnosisHumansLungLung NeoplasmsSensitivity and SpecificityAdenocarcinomaBronchoscopyFine-needle biopsyNeoplasm stagingSmall-cell lung carcinomaSquamous-cell carcinoma

Identifiers

PMID31989234
OpenAlexW3003928120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.